Published in Am Rev Respir Dis on July 01, 1973
Non-tuberculosis mycobacteria in Africa. 1. Isolation and identification. Bull World Health Organ (1967) 1.01
Secretory anti-influenza immunity. Adv Immunol (1976) 0.99
Non-tuberculosis mycobacteria in Africa. 2. Sensitivity to mycobacteriophages. Bull World Health Organ (1967) 0.95
An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil. Bull World Health Organ (1985) 0.95
Non-tuberculosis mycobacteria in Africa. 3. Formamidase activity--its evaluation and practical application. Bull World Health Organ (1967) 0.88
Formation of secretory and circulating antibodies after immunization with live and inactivated influenza virus vaccines. J Infect Dis (1977) 0.86
Some problems of modern influenza prophylaxis with live vaccine. J Infect Dis (1977) 0.83
The chemotherapy of onchocerciasis V. A standard method for the determination of microfilarial density in skin snips. Ann Trop Med Parasitol (1980) 0.81
The kaolin agglutination test with three antigens used for detecting circulating antibodies against tuberculosis in humans, cattle and guinea-pigs. Tubercle (1967) 0.78
Modulation of humoral immune response to influenza vaccines by BCG. Acta Virol (1985) 0.78
[Urbanization and health. XIII. Bacterial and viral infections transmitted rhinopharyngeally in 2 Serer populations (endemic and migrant centers)]. Bull Soc Pathol Exot Filiales (1983) 0.77
Associated seroconversions to respiratory viruses in volunteers with experimental influenza infection. Acta Virol (1976) 0.77
T lymphocytes as an indicator in influenza vaccination, influenza and acute respiratory diseases. Acta Virol (1978) 0.76
A serological test in tuberculosis. A "blind" trial of the kaolin-agglutination test (KAT) for detection of tuberculosis antibodies. Bull World Health Organ (1966) 0.75
[Vaccination against influenza in pulmonary tuberculosis patients]. Probl Tuberk (1980) 0.75
[Influenza vaccination of patients with pulmonary tuberculosis in the tuberculosis dispensary]. Probl Tuberk (1983) 0.75
[Dynamics of the antihemagglutinin level in annual human immunization with inactivated influenza vaccines]. Vopr Virusol (1986) 0.75
Characteristics of antigenic and biological properties of influenza A viruses isolated different epidemics of the same cycle. Ann Microbiol (Paris) (1975) 0.75
Kaolin agglutination test in diagnosis of tuberculosis in Kenya. Tubercle (1966) 0.75
Characteristics of Mycobacterium tuberculosis in Africa. Vulnerable and invulnerable types of drug resistance. Am Rev Respir Dis (1972) 0.75
Characteristics of African M. tuberculosis. Jpn J Tuberc Chest Dis (1970) 0.75
[Primary drug resistance in tuberculosis]. Sov Med (1970) 0.75
[Protecting tuberculosis patients against influenza]. Feldsher Akush (1984) 0.75
[Correlation between the catalase activity and resistance to drugs in Mycobacterium tuberculosis circulating in Southeast Africa]. Zh Mikrobiol Epidemiol Immunobiol (1966) 0.75
[Clinical and epidemiological aspects of influenza chemoprophylaxis with bonaphthone]. Vopr Virusol (1975) 0.75
[Comparative evaluation of 3 methods for the detection of Mycobacterium tuberculosis in smears and impressions from organs]. Lab Delo (1965) 0.75
Routine diagnosis of tuberculosis with phase-contrast microscopy. Am Rev Respir Dis (1974) 0.75
BCG vaccine responses following simultaneous immunization against influenza and tuberculosis. 2nd report. Z Erkr Atmungsorgane (1981) 0.75
Subunit influenza virus vaccine Grippovac SE-AZh (vaccination of adults). Acta Virol (1985) 0.75
Phase-contrast microscopy in diagnosis of tuberculosis. Am Rev Respir Dis (1973) 0.75
[Virulence of Mycobacterium tuberculosis isolated in the far north]. Probl Tuberk (1984) 0.75
Influenza vaccine response following its simultaneous application with BCG 1st report. Z Erkr Atmungsorgane (1981) 0.75
[Bacteriological diagnosis of tuberculosis under conditions of hot climate. 2. Evaluation of the methods of cultures, of phase contrast microscopy and Ziehl-Neelsen in urine study]. Lab Delo (1967) 0.75
[Possibilities for spring vaccination of schoolchildren against influenza]. Zh Mikrobiol Epidemiol Immunobiol (1985) 0.75
[Protection of the elderly against influenza (a review of the literature)]. Vrach Delo (1981) 0.75
[World-wide distribution, isolation and classification of mycobacteria. I. Distribution, frequency and methods of isolation]. Zh Mikrobiol Epidemiol Immunobiol (1966) 0.75
[Catalase positive nature of African cultures of tuberculosis mycobacteria resistant to isoniazid and other preparations]. Zh Mikrobiol Epidemiol Immunobiol (1966) 0.75
[Comparative evaluation of the reactogenicity and antigenic activity of Soviet inactivated influenza vaccines]. Zh Mikrobiol Epidemiol Immunobiol (1984) 0.75
[Soviet mycobacteriology today]. Sov Med (1984) 0.75
[Experimental tuberculous meningoencephalitis in guinea pigs following their inoculation with diverse strains of M. tuberculosis var. hominis]. Probl Tuberk (1970) 0.75
Tuberculosis in Africans. Prolonged observations on drug sensitivity of M. tuberculosis during chemotherapy. Pneumonologie (1974) 0.75
Subunit influenza vaccine and its testing in clinical immunology. J Hyg Epidemiol Microbiol Immunol (1980) 0.75
[Anti-phosphatide antibodies in tuberculosis]. Veterinariia (1971) 0.75
[Present status of the problem of vaccinoprophylaxis against influenza and acute respiratory diseases]. Vestn Akad Med Nauk SSSR (1975) 0.75
[Vaccinal prevention of influenza in children]. Tr Inst Im Pastera (1982) 0.75
[Selection of a method of preserving pathological material from tuberculosis patients for transport in the Far North]. Lab Delo (1983) 0.75
Drug resistance and speed of growth of M. tuberculosis. I. Growth on drug-free medium. Jpn J Tuberc Chest Dis (1971) 0.75
Enhancement of protection against influenza by complex prophylactic schemes. J Hyg Epidemiol Microbiol Immunol (1980) 0.75
Search for optimal scheme for administering live allantoic influenza vaccine. J Hyg Epidemiol Microbiol Immunol (1983) 0.75
Virulence of multidrugresistant Mycobacterium tuberculosis. Exp Pathol (Jena) (1973) 0.75
[Influenza and tuberculosis]. Probl Tuberk (1984) 0.75
[The kaolin agglutination test with phosphatide antigen and its use for the serologic diagnosis of tuberculosis]. Zh Mikrobiol Epidemiol Immunobiol (1966) 0.75
[Modern protection from influenza]. Feldsher Akush (1982) 0.75
[Vaccine prophylaxis of influenza in persons with chronic pathology]. Zh Mikrobiol Epidemiol Immunobiol (1982) 0.75
[Pathomorphology of experimental tuberculosis with varying drug resistance and catalase activity of the causative agent]. Probl Tuberk (1972) 0.75
[Interferon and prevention of influenza]. Feldsher Akush (1984) 0.75
[Bacteriological diagnosis of tuberculosis under conditions of hot climate. 3. Typing of Mycobacterium by means of niacin test]. Lab Delo (1967) 0.75
[Simultaneous vaccination against influenza A and tuberculosis]. Zh Mikrobiol Epidemiol Immunobiol (1983) 0.75
[Dynamics of drug resistance of tuberculosis mycobacteria in long-term chemotherapy]. Sov Med (1971) 0.75
[Bacteriological diagnosis of tuberculosis under the conditions of a hot climate]. Lab Delo (1966) 0.75
[Cross protection in mice immunized with different anti-influenza preparations]. Vopr Virusol (1982) 0.75
Perspectives of cooperation of CMEA countries in combatting influenza. J Hyg Epidemiol Microbiol Immunol (1982) 0.75
[Worldwide distribution, isolation and classification of Mycobacteria. II. Classification and methods of identification]. Zh Mikrobiol Epidemiol Immunobiol (1966) 0.75
[A study of the phage lysability of mycobacteria isolated in Africa]. Zh Mikrobiol Epidemiol Immunobiol (1966) 0.75
[Mycobacteriosis and its causative agents]. Feldsher Akush (1983) 0.75
Experimental tuberculosis with African strains of various drug-resistance. Exp Pathol (Jena) (1972) 0.75
[Evaluation of Mycobacterium tuberculosis virulence by the intracerebral infection of guinea pigs]. Probl Tuberk (1985) 0.75
[Virulence of catalase positive Mycobacterium tuberculosis with various characteristics of drug resistance]. Lab Delo (1971) 0.75
An express method for measuring the virulence of Mycobacterium tuberculosis. J Hyg Epidemiol Microbiol Immunol (1972) 0.75
Simultaneous application of influenza chemovaccine and "Vaxigrip" preparations with BCG. Acta Virol (1983) 0.75
[Experience in using inactivated influenza vaccine with persons at "high risk"]. Tr Inst Im Pastera (1979) 0.75
Basic principles and stages in testing new vaccines against respiratory viruses. Am Rev Respir Dis (1976) 0.75
[Methods and forms of procedures of faculties for increasing the qualifications of medical school teachers]. Sov Zdravookhr (1972) 0.75
[Evaluation of the postvaccination level of influenza antibodies by means of the radial immunodiffusion and hemagglutination inhibition reactions]. Vopr Virusol (1976) 0.75
Drug resistance and speed of growth of M. tuberculosis. 2. Vulnerable and invulnerable types of resistance. Jpn J Tuberc Chest Dis (1971) 0.75
The present and future of specific prophylaxis of influenza and other acute viral respiratory diseases. Am Rev Respir Dis (1974) 0.75